I first interviewed a person with lived experience of substance use twenty years ago. Today, I wanted to pause and reflect on the key points in this
Sending prescribing feedback won’t curb opioid use disorders
REDONNA was a single-blinded, two-arm clinical trial of a prescribing Portrait for eligible family physicians in British Columbia, Canada. It examined
I’m almost opioid-a-phobic: Family medicine residents perceive
Over the past two decades, Canadians’ use of opioid analgesics has substantially grown, making the nation the second-largest user of opioid analgesics
Why inequality hinders effective pain relief for opioid naive people
Equitable access to care is problematic; some people get it, most are left out. The REDONNA study (https://doi.org/10.1016/j.cct.2021.106462) began
Can online training uplift opioid sparing strategies?
Opioid analgesic prescribing has been in trouble for decades in North America. Things are changing, though. Still, there’s room to adjust care,
Exploring barriers and facilitators to health equity
[April 27] The ongoing opioid crisis continues to inflict serious harms on thousands of British Columbians. Some harms are due to initiation of opioid
Newly started primary care opioid prescriptions plateaued in 2018-2019
Our new study published in the Canadian Journal of Addiction found plateauing rates of new starts of opioid analgesics in British Columbia in
Individualized prescribing portraits to reduce inappropriate initiation of opioid analgesics to opioid naïve patients in primary care, REDONNA trial
REDONNA is a mixed-methods randomized study testing the effectiveness of individualized prescribing Portraits to reduce inappropriate initiation of
This changed my practice
Can We Identify Patients at Risk for Opioid Use Disorder when Beginning Opioid Analgesics for Pain from New or Ongoing Non-cancer Causes? There is